D

DaShenLin Pharmaceutical Group Co Ltd
SSE:603233

Watchlist Manager
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Watchlist
Price: 15.3 CNY -5.9% Market Closed
Market Cap: 17.4B CNY
Have any thoughts about
DaShenLin Pharmaceutical Group Co Ltd?
Write Note

DaShenLin Pharmaceutical Group Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

DaShenLin Pharmaceutical Group Co Ltd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
D
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Interest Income Expense
-ÂĄ195.6m
CAGR 3-Years
N/A
CAGR 5-Years
-68%
CAGR 10-Years
N/A
LBX Pharmacy Chain JSC
SSE:603883
Interest Income Expense
-ÂĄ113.5m
CAGR 3-Years
-2%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Yifeng Pharmacy Chain Co Ltd
SSE:603939
Interest Income Expense
-ÂĄ57.9m
CAGR 3-Years
-47%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
Interest Income Expense
-ÂĄ101m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Interest Income Expense
-ÂĄ82.7m
CAGR 3-Years
-134%
CAGR 5-Years
-54%
CAGR 10-Years
-23%
A
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
Interest Income Expense
-ÂĄ14.1m
CAGR 3-Years
-57%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

DaShenLin Pharmaceutical Group Co Ltd
Glance View

Market Cap
17.4B CNY
Industry
Retail

DaShenLin Pharmaceutical Group Co., Ltd. engages in the retail and wholesale of pharmaceutical products. The company is headquartered in Guangzhou, Guangdong and currently employs 38,353 full-time employees. The company went IPO on 2017-07-31. The firm's primary business includes direct sales and retailing of Chinese and Western medicine, ginseng nourishing herbs and Chinese medicine pieces, health products, medical apparatus and instruments and other commodities. The firm mainly conducts its business within domestic market.

Intrinsic Value
44.52 CNY
Undervaluation 66%
Intrinsic Value
Price
D

See Also

What is DaShenLin Pharmaceutical Group Co Ltd's Interest Income Expense?
Interest Income Expense
-195.6m CNY

Based on the financial report for Jun 30, 2024, DaShenLin Pharmaceutical Group Co Ltd's Interest Income Expense amounts to -195.6m CNY.

What is DaShenLin Pharmaceutical Group Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-68%

Over the last year, the Interest Income Expense growth was -1%.

Back to Top